Analysts expect Beam Therapeutics Inc. to report revenue of 7.71 M for Q4 26, against a range of 7.19 M to 8.22 M. The most recent reported quarter, Q3 26, came in at 307,000.00, a 96.4% miss against the 8.50 M consensus.
| Metric | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 30.07 M | 7.47 M | 8.47 M | 9.70 M | 114.11 M | 31.74 M | 490,000.00 | 307,000.00 | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | 17.32 M | 15.71 M | 13.99 M | 11.49 M | 13.26 M | 11.24 M | 18.96 M | 8.95 M | 8.22 M | 4.22 M | 12.18 M | 4.12 M | 14.21 M | 5.86 M | 31.88 M | 16.19 M | |||||||||
| Low Estimate | 14.70 M | 13.11 M | 13.01 M | 10.63 M | 11.58 M | 9.71 M | 15.53 M | 8.05 M | 7.19 M | 3.66 M | 11.29 M | 3.67 M | 11.73 M | 5.10 M | 28.91 M | 14.36 M | |||||||||
| Consensus Estimate | 16.01 M | 14.41 M | 13.50 M | 11.06 M | 12.42 M | 10.47 M | 17.25 M | 8.50 M | 7.71 M | 3.94 M | 11.74 M | 3.90 M | 12.97 M | 5.48 M | 30.39 M | 15.27 M |
Analysts expect Beam Therapeutics Inc. to report earnings per share of -1.24 for Q4 26, against a range of -1.28 to -1.20. The most recent reported quarter, Q3 26, came in at -1.28, a 4.9% miss against the -1.22 consensus.
| Metric | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -1.09 | -1.24 | -1.00 | -1.10 | 2.33 | -0.91 | -1.18 | -1.28 | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | -1.13 | -1.19 | -1.08 | -1.02 | -0.99 | -0.91 | -1.01 | -1.17 | -1.20 | -1.13 | -1.15 | -1.25 | -0.52 | -1.59 | -1.29 | -1.41 | |||||||||
| Low Estimate | -1.23 | -1.29 | -1.28 | -1.18 | -1.11 | -1.03 | -1.11 | -1.27 | -1.28 | -1.25 | -1.39 | -1.47 | -0.58 | -1.73 | -1.39 | -1.67 | |||||||||
| Consensus Estimate | -1.18 | -1.24 | -1.18 | -1.10 | -1.05 | -0.97 | -1.06 | -1.22 | -1.24 | -1.19 | -1.27 | -1.36 | -0.55 | -1.66 | -1.34 | -1.54 |
Pull Wall Street consensus for Beam Therapeutics Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=BEAM&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "BEAM", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=BEAM&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();